6 completed, 3 unknown, 2 terminated, 1 withdrawn. 12 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 6, Unknown 3, Terminated 2, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow proteomic profiling: new trials by email Literature Review of proteomic profiling trials Research Report on proteomic profiling
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Temozolomide in Treating Patients With Invasive Pituitary Tumors temozolomide, DNA methylation analysis, microarray analysis - Brain and Central Nervous System Tumors | Phase 2 | Withdrawn | Jonsson Comprehensive Cancer Center | 2009-12-01 | 2020-07-31 | |
| Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment rituximab, bortezomib, pegylated liposomal doxorubicin hydrochloride - Lymphoma | Phase 2 | Terminated | Roswell Park Cancer Institute | 9 | 2009-01-01 | 2014-07-21 |
| Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer SOD1 inhibitor ATN-224, exemestane, protein expression analysis - Breast Cancer | Phase 2 | Terminated | Cancer Research UK | 111 | 2008-06-01 | 2013-07-10 |
| Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer bevacizumab, carboplatin, erlotinib hydrochloride - Lung Cancer | Phase 2 | Completed | Vanderbilt-Ingram Cancer Center | 116 | 2007-10-01 | 2017-06-08 |
| Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery gemcitabine hydrochloride, oxaliplatin, protein expression analysis - Pancreatic Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 39 | 2007-10-01 | 2017-03-16 |
| Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin FOLFOX regimen, fluorouracil, leucovorin calcium - Chemotherapeutic Agent Toxicity, Colorectal Cancer | Phase 2 | Unknown | Institut Cancerologie de l'Ouest | 206 | 2007-09-01 | 2009-07-08 |
| Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer bevacizumab, cisplatin, irinotecan hydrochloride - Esophageal Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 34 | 2006-04-01 | 2016-05-16 |
| Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors capecitabine, cisplatin, streptozocin - Gastrointestinal Carcinoid Tumor, Islet Cell Tumor | Phase 2 | Completed | Cambridge University Hospitals NHS Foundation Trust | 84 | 2005-08-01 | 2013-08-07 |
| Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery gemcitabine hydrochloride, floxuridine, proteomic profiling - Liver Metastases, Recurrent Colon Cancer | Phase 1 / Phase 2 | Completed | City of Hope Medical Center | 16 | 2005-06-13 | 2026-11-03 |
| Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery cetuximab, celecoxib, proteomic profiling - Colorectal Cancer | Phase 2 | Completed | Vanderbilt-Ingram Cancer Center | 17 | 2005-05-01 | 2012-12-19 |
| Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer cytogenetic analysis, proteomic profiling, cytology specimen collection procedure - Breast Cancer | Phase 2 | Unknown | Royal Marsden NHS Foundation Trust | 60 | 2003-10-01 | 2013-08-26 |
| Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer cytogenetic analysis, proteomic profiling, cytology specimen collection procedure - Breast Cancer | Phase 2 | Unknown | Royal Marsden NHS Foundation Trust | 100 | 2003-09-01 | 2013-08-26 |
Breast Neoplasms (3) · Colonic Neoplasms (3) · Rectal Neoplasms (3) · Colorectal Neoplasms (2) · Adenocarcinoma Of Esophagus (1) · Adenocarcinoma of Lung (1) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Adenoma, Acidophil (1) · Adenoma, Basophil (1) · Adenoma, Chromophobe (1) · Adenoma, Islet Cell (1) · Carcinoma, Islet Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Central Nervous System Neoplasms (1) · Esophageal Neoplasms (1)
Memorial Sloan Kettering Cancer Center (2) · Royal Marsden NHS Foundation Trust (2) · Vanderbilt-Ingram Cancer Center (2) · Cambridge University Hospitals NHS Foundation Trust (1) · Cancer Research UK (1) · City of Hope Medical Center (1) · Institut Cancerologie de l'Ouest (1) · Jonsson Comprehensive Cancer Center (1) · Roswell Park Cancer Institute (1)
United States (6) · United Kingdom (4) · France (1)
Gerald Gui, MD, MS, FRCS(Edin), FRCS(Eng) (2) · Adrian L. Harris, MD (1) · Anthony Heaney, MD (1) · David Carbone, M.D., Ph.D. (1) · David H. Ilson, MD, PhD (1) · Eileen O'Reilly, MD (1) · Erick Gamelin, MD (1) · Jeffrey Wong (1) · Jordan D. Berlin, MD (1) · Myron S. Czuczman, MD (1) · Peter J. Allen, MD (1) · Pippa Corrie, PhD, FRCP (1) · Tim Meyer, MD, BSc, MRCP, PhD (1)
P30CA068485 (2), P30CA008748 (1)